M. Hajiabdolbaghi
发表
Is there any difference between acetylator phenotypes in tuberculosis patients and healthy subjects?
M. Amini,
R. Mahjub,
H. Khalili,
2010,
European Journal of Clinical Pharmacology.
E. Azizi,
K. Gholami,
R. Mahjub,
2011,
Iranian journal of pharmaceutical research : IJPR.
M. Mohebali,
S. Jafari,
M. Hajiabdolbaghi,
2010,
Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
M. Davarpanah,
H. Naderi,
H. Khalili,
2022,
Journal of clinical pharmacy and therapeutics.
M. Hajiabdolbaghi,
S. Jafari,
S. Mansouri,
2014,
Medical journal of the Islamic Republic of Iran.
H. Khalili,
M. Hajiabdolbaghi,
M. Farasatinasab,
2012,
The Annals of pharmacotherapy.
Hossein Khalili,
SeyedAhmad SeyedAlinaghi,
H. Khalili,
2012,
Current clinical pharmacology.
M. Dallal,
M. Hajiabdolbaghi,
M. Abdi,
2016
.
L. Abbasian,
S. Kalantari,
Katayoun Tayeri,
2017,
Iranian journal of microbiology.
S. Fouladdel,
E. Azizi,
H. Khalili,
2011,
Current drug safety.
M. Hajiabdolbaghi,
M. K. Sharifi Yazdi,
M. Abdi,
2016,
New microbes and new infections.
S. S. Alinaghi,
Sara Sardashti,
M. Hajiabdolbaghi,
2015
.
J. Yavarian,
K. Sadeghi,
V. Salimi,
2023,
Journal of Medical Virology.
H. Khalili,
M. Hajiabdolbaghi,
Maryam Farasatinasab,
2012,
The Annals of pharmacotherapy.